Topics: Genetic, Study, Unique Case
An Oxford resident became the first person in the world to try out gene therapy on herself to stop vision loss. As noted by the BBC, scientists have introduced into the patient's body an artificial gene in order to prevent retinal cell death.
This is the first therapy aimed at the genetic basis of age-related macular degeneration. The macula is the part of the retina responsible for the central field of view and the visibility of precise details. With age-related degeneration, retinal cells begin to die, and their supply does not resume.
According to the researchers, the injection is done at an early stage of the development of degeneration in the back of the eye. With it, the body receives a harmless virus with a synthetic gene. The virus infects the cells of the retina and releases the "stuffing" - the gene.
The presence of the inserted gene allows the body to independently produce a protein that inhibits cell death. While talking about the results of the test therapy early. Now scientists are monitoring the patient's condition.